blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3290434

EP3290434 - PEPTIDE HAVING ANTI-DIABETIC AND ANTI-OBESITY EFFECTS, AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.06.2021
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  17.07.2020
FormerGrant of patent is intended
Status updated on  06.04.2020
FormerExamination is in progress
Status updated on  09.04.2019
FormerRequest for examination was made
Status updated on  02.02.2018
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Caregen Co., Ltd.
46-38 LS-ro 91beon-gil
Dongan-gu
Anyang-si, Gyeonggi-do 431-848 / KR
[2018/10]
Inventor(s)01 / CHUNG, Yong Ji
101-1202 Sungdong Maeul LG
Village 1Cha Apt.
86 Seongbok 2-ro
Suji-gu
Yongin-si Gyeonggi-do 448-980 / KR
02 / KIM, Eun Mi
105-1103 Beodeulchi Maeul
Kyoungnam Honors Ville 2 Cha Apt.
11 Seongbok 1-ro 163beon-gil
Suji-gu
Yongin-si Gyeonggi-do 448-739 / KR
 [2018/10]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2018/10]
Application number, filing date15890803.812.05.2015
[2018/10]
WO2015KR04749
Priority number, dateKR2015005964828.04.2015         Original published format: KR 20150059648
[2018/10]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016175362
Date:03.11.2016
Language:KO
[2016/44]
Type: A1 Application with search report 
No.:EP3290434
Date:07.03.2018
Language:EN
[2018/10]
Type: B1 Patent specification 
No.:EP3290434
Date:19.08.2020
Language:EN
[2020/34]
Search report(s)International search report - published on:KR03.11.2016
(Supplementary) European search report - dispatched on:EP16.07.2018
ClassificationIPC:C07K7/06, A61K38/08, A61P3/00, A61P3/06, A61P3/10, A61K38/30, A61K38/22
[2018/33]
CPC:
A61K38/08 (EP,US); C12N5/10 (IL); C07K7/06 (US);
A61K38/2264 (EP,US); A61K38/30 (EP,US); A61K39/395 (IL);
A61P3/00 (EP,US); A61P3/04 (EP,US); A61P3/06 (EP,US);
A61P3/10 (EP,US); C07K14/5759 (EP); A61K38/00 (EP,US) (-)
Former IPC [2018/16]C07K7/06, A61K38/08, A61P3/00, A61P3/06, A61P3/10
Former IPC [2018/10]C07K7/06, A61K38/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:PEPTID MIT ANTIDIABETISCHER WIRKUNG UND WIRKUNG GEGEN FETTLEIBIGKEIT SOWIE VERWENDUNG DAVON[2018/10]
English:PEPTIDE HAVING ANTI-DIABETIC AND ANTI-OBESITY EFFECTS, AND USE THEREOF[2018/10]
French:PEPTIDE AYANT DES EFFETS ANTI-DIABÉTIQUES ET ANTI-OBÉSITÉ, ET SON UTILISATION[2018/10]
Entry into regional phase10.11.2017Translation filed 
10.11.2017National basic fee paid 
10.11.2017Search fee paid 
10.11.2017Designation fee(s) paid 
10.11.2017Examination fee paid 
Examination procedure10.11.2017Examination requested  [2018/10]
10.11.2017Date on which the examining division has become responsible
07.02.2019Amendment by applicant (claims and/or description)
12.04.2019Despatch of a communication from the examining division (Time limit: M04)
06.08.2019Reply to a communication from the examining division
30.09.2019Despatch of a communication from the examining division (Time limit: M04)
27.01.2020Reply to a communication from the examining division
07.04.2020Communication of intention to grant the patent
08.07.2020Fee for grant paid
08.07.2020Fee for publishing/printing paid
08.07.2020Receipt of the translation of the claim(s)
Divisional application(s)EP19199355.9  / EP3613758
EP19199388.0  / EP3613759
EP19199390.6  / EP3613760
Opposition(s)20.05.2021No opposition filed within time limit [2021/30]
Fees paidRenewal fee
10.11.2017Renewal fee patent year 03
14.05.2018Renewal fee patent year 04
10.05.2019Renewal fee patent year 05
30.03.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.05.2015
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
MK19.08.2020
MT19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
TR19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
[2024/41]
Former [2024/29]HU12.05.2015
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
MK19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
TR19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
Former [2024/22]HU12.05.2015
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
MK19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
Former [2023/30]HU12.05.2015
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
Former [2023/29]HU12.05.2015
AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
Former [2022/21]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
IE12.05.2021
LU12.05.2021
Former [2022/09]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
LU12.05.2021
Former [2022/07]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/36]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/28]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/25]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/23]AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/22]CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/21]DK19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/10]FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/09]FI19.08.2020
LT19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
PT21.12.2020
Former [2021/08]FI19.08.2020
LT19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
PT21.12.2020
Former [2021/07]FI19.08.2020
LT19.08.2020
NO19.11.2020
Documents cited:Search[XA]WO9308826  (CEPHALON INC [US]) [X] 1-7 * the whole document * * sequence 19 * * page 6, lines 14-15 * [A] 8-16;
 [Y]WO02069232  (MERCK PATENT GMBH [DE], et al) [Y] 1-16 * the whole document *;
 [XA]US6693076  (LEWIS MICHAEL E [US], et al) [X] 1-7 * the whole document *[A] 8-16;
 [Y]WO2007087468  (CHILDRENS HOSP MEDICAL CENTER [US], et al) [Y] 1-16 * the whole document *;
 [XA]WO2007102686  (CAREGEN CO LTD [KR], et al) [X] 1-7 * the whole document * * example 3 * [A] 8-16;
 [Y]WO2007141309  (NOVARTIS AG [CH], et al) [Y] 1-16 * the whole document *;
 [Y]WO2014052451  (UNIV INDIANA RES & TECH CORP [US]) [Y] 1-16 * the whole document * * sequence 5 * * claims 1, 5 *;
 [Y]  - UJIIE HIDETOSHI ET AL, "Identification of amino-terminal region of adiponectin as a physiologically functional domain", JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS INC, US, (20060501), vol. 98, no. 1, doi:10.1002/JCB.20779, ISSN 0730-2312, pages 194 - 207, XP002476528 [Y] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1002/jcb.20779
International search[A]US6087334  (BEELEY NIGEL ROBERT ARNOLD [US], et al) [A] 1-14 * See the entire document. *;
 [A]US2014018291  (VIGNATI LOUIS [US], et al) [A] 1-14* See the entire document. *;
 [A]KR20140027594  (CGK BIO INC [KR]) [A] 1-14 * See the entire document. *;
 [A]KR20140134083  (CAREGEN CO LTD [KR]) [A] 1-14 * See abstract; claims 1-9, 16, 17; table 1. *;
 [A]  - Genbank, (20070620), Database accession no. EDL89718.1, XP055326499 [A] 1-14 * See the entire document. *
 [A]  - Genbank, (20090305), Database accession no. ABG01984.1, XP055326501 [A] 1-14 * See the entire document. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.